EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sperm and offspring production in a nonobstructive azoospermia mouse model via testicular mRNA delivery using lipid nanoparticles

Daisuke Mashiko iD, Chihiro Emori, Yuki Hatanaka, Daisuke Motooka, Chen Pan, Yuki Kaneda iD, Martin M Matzuk iD, Masahito Ikawa iD

Proceedings of the National Academy of Sciences · 21.10.2025 · 122 (42)

DOI: 10.1073/pnas.2516573122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.10.2025. Verfasst von Daisuke Mashiko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Nanoparticles, Azoospermia, RNA, Messenger, Testis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Japan Agency for Medical Research and Development (AMED), NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microsurgical testicular sperm extraction (microTESE) with intracytoplasmic sperm injection (ICSI) represents the current standard treatment for nonobstructive azoospermia (NOA). However, cures remain unavailable for NOA patients lacking retrievable haploid cells. mRNA supplementation could be a potential treatment for genetic defects leading to impaired spermatogenesis. Lipid nanoparticles (LNPs) have emerged as mRNA delivery vehicles with minimal risk of genome integration; however, their ability to selectively deliver mRNA to specific cell types remains limited. To overcome this, microRNA (miRNA) target sequences were incorporated into mRNA constructs to restrict expression specifically to germ cells. Using pyruvate dehydrogenase E1 subunit alpha 2 (PDHA2) knockout mice as an NOA model with meiotic arrest, we demonstrate that LNP-mediated delivery of Pdha2 mRNA enables the resumption and completion of meiosis, restores sperm production, and facilitates the generation of healthy fertile offspring via ICSI. Whole-genome sequencing of the offspring confirmed the absence of large-scale genomic abnormalities. Our results provide proof of concept for a safe and effective chemically synthesized LNP-based mRNA therapy with miRNA-regulated germ cell specificity, offering a promising therapeutic approach to treating male infertility caused by spermatogenesis arrest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAzoospermiaRNA, MessengerTestisSpermatozoaLipidsAnimalsMaleMiceMice, KnockoutDisease Models, AnimalSpermatogenesisSperm Injections, IntracytoplasmicMicroRNAsLiposomes

Stichwörter der Autor:innen

LNP therapyazoospermiagermline therapylipid nanoparticlesterility

Substanzen

RNA, MessengerLipidsLipid NanoparticlesMicroRNAsLiposomes

Autor:innen und Institutionen

  • Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka 565-0871, Japan.
  • Next Generation Sequencing Core Facility, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka 565-0871, Japan.
  • Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030.
  • Center for Advanced Modalities and Drug Delivery System, The University of Osaka, Osaka 565-0871, Japan.
  • Center for Infectious Disease Education and Research, The University of Osaka, Osaka 565-0871, Japan.
  • The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.

ORCID-Profile: Daisuke Mashiko, Yuki Kaneda, Martin M Matzuk, Masahito Ikawa

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Japan Agency for Medical Research and Development (AMED)
  • NICHD NIH HHS
  • MEXT | Japan Science and Technology Agency (JST)
  • HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Zitieren

APA

Mashiko, D., Emori, C., Hatanaka, Y., Motooka, D., Pan, C., Kaneda, Y., Matzuk, M. M., & Ikawa, M. (2025). Sperm and offspring production in a nonobstructive azoospermia mouse model via testicular mRNA delivery using lipid nanoparticles. Proceedings of the National Academy of Sciences, 122(42). https://doi.org/10.1073/pnas.2516573122

Vancouver

Mashiko D, Emori C, Hatanaka Y, Motooka D, Pan C, Kaneda Y, et al. Sperm and offspring production in a nonobstructive azoospermia mouse model via testicular mRNA delivery using lipid nanoparticles. Proceedings of the National Academy of Sciences. 2025;122(42). doi:10.1073/pnas.2516573122

BibTeX
@article{Mashiko2025,
  author = {Mashiko, Daisuke and Emori, Chihiro and Hatanaka, Yuki and Motooka, Daisuke and Pan, Chen and Kaneda, Yuki and Matzuk, Martin M and Ikawa, Masahito},
  title = {Sperm and offspring production in a nonobstructive azoospermia mouse model via testicular mRNA delivery using lipid nanoparticles},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {42},
  doi = {10.1073/pnas.2516573122}
}
Kostenlos starten →